Member Database

Porama Thanaporn

Clinical Assistant Professor
Internal Medicine
Medicine

MD, University of Michigan

Dr. Thanaporn’s primary interests are in repurposing old drugs for new indications and the use of novel therapeutics in heart failure. He is also interested in heart failure outcomes and clinical trial design. He is currently co-PI for EMERALD-HF, a precision medicine heart failure trial in China using spironolactone in patients with aldehyde dehydrogenase type 2 deficiency, a common hereditary disorder that interferes with the metabolism of alcohol.


Projects:

EMERALD-HF: Evaluation of MinERalocorticoid antagonists in ALdehyde dehydrogenase type 2 Deficiency

University Affiliation(s)

Global REACH | IHPI | MiCHAMP

Research Area(s)

Clinical research | Global Health | cardiovascular diseases